Director, Data, Data Science and Artificial Intelligence – Oncology / Prostate Cancer

Scorpion Therapeutics; Raritan (NJ); On-site; USD 150,000 - 210,000; Full time

Job summary

Scorpion Therapeutics seeks a Director in its Johnson & Johnson Data Science Portfolio Management team to drive AI-driven endpoints for oncology programs. You will lead development and validation efforts, harness advanced analytics, and shape collaborative strategies for trial design and regulatory submissions.

The role requires 8+ years in drug development or data science, with expertise in high-dimensional healthcare data and oncology.

Qualifications

• PhD/MD/PharmD or MS with 8+ years in drug development or data science.
• Experience with high-dimensional healthcare data (EHR, imaging, omics) and oncology.
• Strong collaboration across medical, regulatory, and clinical development teams.

Responsibilities

• Lead development and validation of AI endpoints for oncology programs.
• Leverage analytics and ML/AI tools to derive trial insights.
• Drive collaborations with medical, regulatory, and clinical teams to support submissions.

Skills

Data science

Biostatistics

Machine learning

Oncology

Clinical trial analytics

Education

PhD, MD, PharmD, or MS

Tools

R

Python

ML/AI tooling

Job description

Role: Director within Johnson & Johnson's Data Science Portfolio Management team, focusing on innovative data-driven solutions for Oncology, specifically Prostate Cancer.

Responsibilities: lead development and validation of novel AI endpoints, leverage advanced analytics and ML/AI tools for clinical trial insights, and drive strategic collaborations to transform Oncology research. Collaborate across functions such as medical, regulatory, and clinical development to deploy data science solutions supporting trial design and regulatory submissions.

Qualifications: PhD, MD, PharmD, or MS with 8+ years in drug development, biostatistics, data science, or outcomes research, with experience in high-dimensional datasets, healthcare data (EHR, imaging, omics), and oncology.

Preferred: knowledge of genitourinary cancers, hematology/oncology training, and R&D experience in pharma or biotech.

High-Value: oncology (Prostate Cancer), clinical-stage programs, AI endpoint development, real-world evidence, external partnerships.

Work setup: on-site in NJ, PA, CA, or MA with up to 10% travel.